clinical trial · NCT05109091
Study of ATH434 in Participants with Multiple System Atrophy
Multiple System AtrophyATH434 dose level 1ATH434 dose level 2Placebo
brief summary
This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy
started
Jul 1, 2022
primary completion
Nov 28, 2024
completion
Nov 28, 2024
last updated
Dec 13, 2024
official title
A Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in Multiple System Atrophy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol